Ownership of Joint Technology. Subject to Section 6.2 and the license grants under Article 2, the Parties shall each own an equal, undivided interest in and to any and all (a) Information and Inventions, conceived, discovered, developed or otherwise made, jointly by or on behalf of NovaDel (or its Affiliates or its sublicensees), on the one hand, and Licensee (or its Affiliates or Sublicensees), on the other hand, in connection with the work conducted under or in connection with this Agreement, whether or not patented or patentable; and (b) Patents (the "Joint Patents") and other intellectual property rights with respect thereto (collectively, the "Joint Technology"). Each Party shall promptly disclose to the other Party in writing, and shall cause its Affiliates, licensees and sublicensees to so disclose, the development, making, conception or reduction to practice of any Joint Technology.
Appears in 4 contracts
Samples: License and Development Agreement (Manhattan Pharmaceuticals Inc), License and Development Agreement (Manhattan Pharmaceuticals Inc), License and Development Agreement (Novadel Pharma Inc)